Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
Clinical trial NCT04057898 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04057898
- Sponsor
- MediciNova
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2027-04-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.